Cytokinetics, Inc. (NASDAQ:CYTK) Q4 2019 Earnings Conference Call March 3, 2020 4:30 PM ET Company Participants Diane Weiser - VP, IR & Corporate Communications Robert Wong - VP & CAO Fady Malik - EVP, Research & Development Andrew Wolff - SVP, Senior Fellow, Clinical Research & Development Robert Blum - CEO, President & Director Ching Jaw - SVP & CFO Conference Call Participants Jason Butler - JMP Securities Joseph Pantginis - H.C. Wainwright & Co. Chad Messer - Needham & Company Jeff Hung - Morgan Stanley ...

1 EMPOWERING MUSCLE EMPOWERING LIVES Forward Looking Statements This Presentation contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Cytokinetics disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Act's Safe Harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to Cytokinetics' and its partners' research and developm ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 From the transition period from to Commission file number: 000-50633 | --- | --- | |------------------------------------------------------------------------------------------------------|------- ...